ERIC BJERKHOLT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Microbot Medical Inc.

Filing Date Source Excerpt
2010-04-13 Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Senior Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. ... The Compensation Committee has been composed of Dr. Schwartz and Mr. Bjerkholt. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... The following table summarizes compensation information for our non-employee directors ... Eric Bjerkholt: Total $54,019.
2011-05-17 Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Senior Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. ... Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... Mr. Bjerkholt is an audit committee financial expert. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation and Strategic Transactions Committees. ... Director Compensation Table: Eric Bjerkholt Fees Earned in Cash $51,500, Stock Awards $11,800, Total $63,300.
2012-04-27 Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. ... The Corporate Governance Committee is composed of Drs. Levy, Perlmutter and Schwartz. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation and Corporate Governance Committees. ... Director Compensation Table shows Eric Bjerkholt fees earned or paid in cash $53,500, Stock Awards $9,100, Total $62,600.
2013-10-31 The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held four meetings during the fiscal year ended December 31, 2012. ... Mr. Bjerkholt is an "audit committee financial expert," as defined in SEC rules. ... The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. ... The Corporate Governance Committee is composed of Drs. Levy, Perlmutter and Schwartz. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair Audit Committee, Compensation Committee, Corporate Governance Committee. ... Director Compensation Table: Eric Bjerkholt Fees Earned or Paid in Cash $52,500, Stock Awards $10,280, Total $62,780.
2014-04-30 Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held five meetings during the fiscal year ended December 31, 2013. Each of the members of the Audit Committee is independent, and the Board has determined that Mr. Bjerkholt is an audit committee financial expert, as defined in SEC rules. The Audit Committee acts pursuant to a written charter which is available through our website at www.stemcellsinc.com. The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. The Compensation Committee held eight meetings during the fiscal year ended December 31, 2013. The Corporate Governance Committee was composed of Drs. Levy and Schwartz and a former member of our Board of Directors, Dr. Roger Perlmutter, who resigned from our Board in December 2013. Following Dr. Perlmutter's resignation in December 2013, the Board appointed Mr. Greer to the Corporate Governance Committee. The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation Committee and Corporate Governance Committee. Director compensation table shows Eric Bjerkholt earned $74,500 in 2013.
2015-04-30 Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Bjerkholt is a member of the board of directors of Ambrx, Inc. and Corium International, Inc. The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held four meetings during the fiscal year ended December 31, 2014. Each of the members of the Audit Committee is independent, and the Board has determined that Mr. Bjerkholt is an audit committee financial expert, as defined in SEC rules. The following table summarizes cash-based and equity compensation information for our outside directors for the year ended December 31, 2014: Eric Bjerkholt Fees Earned or Paid in Cash $54,250, Stock Awards $61,784, Total $116,034.
2016-04-08 Eric Bjerkholt was elected to the Board of Directors of StemCells, Inc. in March 2004. Mr. Bjerkholt chairs our Audit Committee. He is Executive Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a small molecule biopharmaceutical company. ... The following table summarizes cash-based and equity compensation information for our outside directors, including annual Board and committee retainer fees and meeting attendance fees, for the year ended December 31, 2015: ... Eric Bjerkholt Fees Earned or Paid in Cash $64,250, Stock Awards $60,000, Total $124,250.

Data sourced from SEC filings. Last updated: 2026-02-03